ClinicalTrial | Financial Buzz

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Evaxion Biotech (NASDAQ: EVAX) Reaches Milestone in EVX-01 Development

financial buzz09/21/2022

16413

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Evaxion Biotech Reaches Milestone in EVX-01 Development” Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: IVERIC bio, Inc. (NASDAQ: ISEE) Positive Zimura Trial Results

financial buzz09/06/2022

17367

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “IVERIC bio, Inc. Shares Soar Amid Positive Zimura Trial Resultsl” IVERIC bio, Inc. (NASDAQ: ISEE) announced positive topline...

AI Automotive Breaking News Market News Medical Use Pharmaceutical Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: T2 Biosystems (NASDAQ: TTOO) to Explore Potential Diagnostic Test for Monkeypox

financial buzz08/10/2022

16467

No views Aug 10, 2022 FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “T2 Biosystems to Explore Potential to Develop Rapid Molecular Diagnostic Test for Monkeypox...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Otonomy Announces Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus

Andy Liao08/01/2022

16433

Otonomy, Inc. (NASDAQ: OTIC) reported that the OTO-313 Phase 2 trial in tinnitus demonstrated no meaningful benefit versus placebo for primary and secondary endpoints across all timepoints. The phase...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Aditxt (NASDAQ: ADTX) Toxicity Study Psoriasis Drug Candidate ADI™-100

financial buzz07/08/2022

17402

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Aditxt, Inc. Successfully Completes Preclinical Toxicity Study of Its Psoriasis Drug Candidate ADI™-100” Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Day One Reports Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib in Relapsed Pediatric Glioma

Andy Liao06/13/2022

16562

Day One Biopharmaceuticals (NASDAQ: DAWN) has announced positive initial data for the first 22 Response Assessment for Neuro-Oncology evaluable patients enrolled in the on going phase 2 FIREFLY-1 clinical...

Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer to Supply 4 Million Paxlovid Doses to UNICEF

Rebecca Urena03/22/202203/22/2022

18322

Pfizer (NYSE: PFE) is set to provide up to 4 million doses of its Covid-19 pill, Paxlovid, to low and middle-income countries amid an agreement with Unicef, the global...

Tag: ClinicalTrial